INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (6.005)
2024
-
A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations
International Journal of Molecular Sciences, Vol. 25, Núm. 3
-
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study
Haematologica, Vol. 109, Núm. 3, pp. 867-876
-
Acute pulmonary embolism masking a pulmonary artery sarcoma
Medicina Clinica
-
Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis
Antioxidants, Vol. 13, Núm. 1
-
Assessing the Effectiveness of Textual Recommendations in KoopaML: A Comparative Study on Non-Expert Users' ML Pipeline Development
International Journal on Semantic Web and Information Systems, Vol. 20, Núm. 1
-
Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes
JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72
-
CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents (ESAs)
Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 22, Núm. 25
-
COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS: A SERIES OF 5 CASES
European Journal of Case Reports in Internal Medicine, Vol. 11, Núm. 1
-
Cardiac segments dosimetric benefit from deep inspiration breath hold technique for left-sided breast cancer radiotherapy
Reports of Practical Oncology and Radiotherapy, Vol. 29, Núm. 1, pp. 21-29
-
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 24, Núm. 4, pp. 224-231.e2
-
Characterization of seven novel HLA-DPA1*01:03:01 non-coding variants by next-generation sequencing
HLA, Vol. 103, Núm. 2
-
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers
British Journal of Surgery, Vol. 111, Núm. 3
-
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 2, pp. 696-715
-
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 4, pp. 1576-1593
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
-
Comparison of the Analgesic Efficacy between Levobupivacaine 0.25% and Ropivacaine 0.375% for PENG (Pericapsular Nerve Group) Block in the Context of Hip Fracture Surgery of Elderly Patients: A Single-Center, Randomized, and Controlled Clinical Trial
Journal of Clinical Medicine, Vol. 13, Núm. 3
-
Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology
PLoS Computational Biology, Vol. 20, Núm. 2
-
Cuidados continuos en Oncología (I): generalidades
Oncología clínica (Arán Ediciones), pp. 147-155
-
Cuidados continuos en oncología (II): control de los principales síntomas y del dolor, cuidados en el final de la vida, duelo
Oncología clínica (Arán Ediciones), pp. 157-173
-
Cuidados continuos en oncología (III): infecciones en el paciente con cáncer, neutropenia febril
Oncología clínica (Arán Ediciones), pp. 175-188